Literature DB >> 6798099

Development and characteristics of sucralfate.

R Nagashima.   

Abstract

Sucralfate, a basic aluminum salt of sucrose octasulfate, was developed to counteract the activities of both acid and pepsin. It differs chemically from other sulfated anionic inhibitors of pepsin in being a base and a derivative of pure disaccharide sucrose. The development of sucralfate was guided by the observations that sulfated disaccharides do not exhibit the anticoagulant activity of sulfated polysaccharides, and that the inhibition of peptic activity and the protection against experimental ulceration depend only on the degree of sulfation. Sucralfate has been found to protect pylorusligated animals from peptic ulceration more effectively than a mixture of sucrose octasulfate and aluminum hydroxide. Sucralfate has several unusual properties. On encountering gastric acid, it becomes a highly condensed, viscous substance with the capacity to buffer acid. These properties are retained in the duodenum. Sucralfate forms stable complexes with proteins and inhibits their hydrolysis by preventing pepsin-substrate interaction. Sucralfate also inhibits peptic activities by direct adsorption of pepsin. In addition, sucralfate adsorbs bile salts. The sum of these properties implies that sucralfate provides a comprehensive defense against identified aggressive factors, acid, pepsin, and bile salts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798099

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  30 in total

1.  The effect of residual water on antacid properties of sucralfate gel dried by microwaves.

Authors:  Alessandro Gainotti; Elena Losi; Paolo Colombo; Patrizia Santi; Fabio Sonvico; Daniela Baroni; Gina Massimo; Gaia Colombo; Pasquale Del Gaudio
Journal:  AAPS PharmSciTech       Date:  2006-01-20       Impact factor: 3.246

2.  Gastric surfactant and the hydrophobic mucosal barrier.

Authors:  B A Hills
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

4.  Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.

Authors:  J P Wright; T A Winter; S Candy; I S Marks
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

5.  Sucralfate reduces the gastrointestinal absorption of norfloxacin.

Authors:  S H Parpia; D E Nix; L G Hejmanowski; H R Goldstein; J H Wilton; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

6.  "Buffering" activity of sucralfate.

Authors:  M Guslandi
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

7.  Effect of intragastric pH on mucosal protective action of sucralfate.

Authors:  J Z Danesh; A Duncan; R I Russell; G Mitchell
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

8.  Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine.

Authors:  B Hallerbäck; O Anker-Hansen; L Carling; H Glise; J H Solhaug; L E Svedberg; L Wählby
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

9.  Effects of ranitidine and sucralfate on ketoconazole bioavailability.

Authors:  S C Piscitelli; T F Goss; J H Wilton; D T D'Andrea; H Goldstein; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Effect of drying methods on retention of moist sucralfate gel properties.

Authors:  L Maggi; P L Catellani; E Fisicaro; P Santi; F Zani; G Massimo; P Colombo
Journal:  AAPS PharmSciTech       Date:  2000-09-22       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.